OR6C1: A GPCR Molecule Responsible for Nose Sensitivity (G390321)

OR6C1: A GPCR Molecule Responsible for Nose Sensitivity

Olfactory receptor 6C1 (OR6C1) is a G protein-coupled receptor (GPCR) that is expressed in the olfactory system of the nose. It is responsible for mediating the sense of smell, and is a target for several drugs, including some anti-cancer drugs.

OR6C1 is a member of the superfamily of GPCR, which includes over 300 different genes that are expressed in the nervous system. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and cell survival.

OR6C1 is a transmembrane protein that is expressed in the olfactory epithelium, which is the lining of the olfactory organs. It is composed of an extracellular portion, a transmembrane region, and an intracellular portion that contains a catalytic active site and a regulatory region.

The OR6C1 receptor is involved in the sense of smell, which is the ability to detect and identify different odors. When an odor is introduced to the nostril, it reaches the OR6C1 receptor and triggers a signaling cascade that results in the sensation of smell.

OR6C1 is a dendritic receptor, which means that it is involved in receiving signals from the nose. It is surrounded by a network of nerve cells that are responsible for transmitting the sense of smell to the brain. When an odor is introduced to the nose, it reaches the OR6C1 receptor, which then triggers a signaling cascade that is transmitted to the brain.

OR6C1 is a protein that is expressed in the olfactory system, and it is involved in the sense of smell. It is a potential drug target, and several studies have investigated its role in cancer treatment.

Protein Name: Olfactory Receptor Family 6 Subfamily C Member 1

Functions: Odorant receptor

The "OR6C1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR6C1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1